Skip to content

Ospoplus

Active
Private limited companyfounded 2023active for 3 yearsGroenstraat 41, 3078 Kortenberg, BelgiumKBO/BCE: BE 0802.820.104
Summary

Ospoplus has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€2,639) and a net result of -€3,729. Its solvency ranks better than 5% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Overview

Official details

Source: KBO
Status
Active since 16-06-2023 Normal situation
Activity
Physiotherapy NACE 86951and 3 others
Establishment unit
2.346.258.566 3078 Kortenberg, since 16-06-2023
Financial year end
31 December
Peppol
Reachable since 02-10-2025

Board and ownership

Board

Financial position

52 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
-€3,675
▼ 198%
Loss
€3,729
▲ 185%
Equity
-€2,639
Total assets
€1,147
▼ 53.9%
  • Negative equity on 31-12-2025
  • 2025 accounts filed 28 days after the deadline
Turnover not published (micro format)
Score breakdownraises riskCapped at 59: negative equityNegative equity -€2,639Loss of €3,729, the second in a row (financial year 2025)lowers riskSector: Human health activities (NACE 86)Size: total assets €1,147Show the evidence

Checked score

Score 2025
52 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially stronger than 6% of micro companies in human health (NACE 86)
Negative equity caps the score at 59. Every signal that counts is listed under Signals.
Financial strength · tick: 2024
Weak
Solvency 0-69
equity -230.1% of total assets
Liquidity 50-21
short-term debt 330.1% · cash 100.0%
Profitability 0=
return on assets -325.1%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.4% 01-2025: 0.4%● unchanged vs 12-2024 02-2025: 0.4%● unchanged vs 01-2025 03-2025: 0.4%● unchanged vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025highest value 08-2025: 0.1%▼ -0.3 percentage points vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
No credit on open account
The balance sheet total is too small for a liquidity verdict. Equity is negative.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 1% of them on solvency, 20% on liquidity, 1% on profitability and 0% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Negative equity -€2,639
NBB · annual accounts
lowers risk · Size: total assets €1,147
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Loss of €3,729, the second in a row (financial year 2025)
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
2425
2024 to 2025 · latest year -€2,639
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
28 days late
2024
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 2 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Financials

Financials · financial year 2025, micro format

2025 annual accounts filed 28 days after the deadline Filed on 28 August 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00491425.

Annual accounts 2025 filed on 28-08-2026 at the NBB all 2 filings

Turnover
€2,482
EBIT margin
-49.7%
Net result
-€3,729▼ 185%
2024 · -€1,310
Working capital
-€2,639
2024 · €1,090
Multi-year overview
2024 to 2025, 2 financial years
Turnover
no figure
2025
20242025
Operating result
-€3,675
▼ 198% 2025
20242025
Net result
-€3,729
▼ 185% 2025
lowest quarter of the sector
20242025
EBIT margin
no figure
2025
20242025
Equity
-€2,639
2025
lowest quarter of the sector
20242025
Total assets
€1,147
▼ 53.9% 2025
lowest quarter of the sector
20242025
Debt
€3,786
▲ 171% 2025
20242025
Working capital
-€2,639
2025
lowest quarter of the sector
20242025
Every figure per financial year
Every figure with its change against the financial year before
favourable unfavourable
Line20242025
Turnover€2,482-
Operating result-€1,234--€3,675▼ 198%
Net result-€1,310below the sector's middle half--€3,729below the sector's middle half▼ 185%
EBIT margin-49.7%-
Equity€1,090below the sector's middle half--€2,639below the sector's middle half
Total assets€2,489below the sector's middle half-€1,147below the sector's middle half▼ 53.9%
Debt€1,399-€3,786▲ 171%
Working capital€1,090below the sector's middle half--€2,639below the sector's middle half
above within below The sector band is the middle half of the companies in Human health activities (NACE 86). A quarter of them sit below it, a quarter above. Each year counts only accounts in the same format, and only where there are at least 30.

The operating result for 2025 is a loss of €3,675, larger than the loss of €1,234 in 2024.

Key figures and ratios
2025 value · change against 2024
Debt ≤ 1 year
€3,786▲
2024 · €1,399
The ratios are withheld because a balance sheet total of €1,147 is too small for a meaningful ratio.
Green means a favourable move, even when the figure itself falls, as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 27 lines
Balance sheet Code20242025
Assets
Total assets20/58€2,489€1,147▼
Current assets29/58€2,489€1,147▼
Amounts receivable within one year40/41€440-
Trade receivables40€440-
Cash at bank and in hand54/58€2,049€1,147▼
Equity and liabilities
Total equity and liabilities10/49€2,489€1,147▼
Equity10/15€1,090-€2,639▼
Contributions10/11€2,400€2,400=
Profit (loss) carried forward14-€1,310-€5,039▼
Amounts payable17/49€1,399€3,786▲
Amounts payable within one year42/48€1,399€3,786▲
Trade debts44€6€179▲
Suppliers440/4€6€179▲
Other amounts payable47/48€1,393€3,607▲
Income statement Code20242025
Turnover70€2,482-
Goods, raw materials, services and sundry goods60/61€41,596-
Gross operating margin9900-€1,234-€3,675▼
Operating profit (loss)9901-€1,234-€3,675▼
Financial income75/76B€1-
Recurring financial income75€1-
Financial charges65/66B€77€54▼
Recurring financial charges65€77€54▼
Profit (loss) for the period before taxes9903-€1,310-€3,729▼
Profit (loss) for the period9904-€1,310-€3,729▼
Profit (loss) for the period to be appropriated9905-€1,310-€3,729▼
Appropriation of the result
Profit (loss) to be appropriated9906-€1,310-€5,039▼
Profit (loss) brought forward from the previous period14P--€1,310

The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 28-08-2026.

Line20242025Change
Turnover70€2,482--
Goods, raw materials, services and sundry goods60/61€41,596--
Gross operating margin9900-€1,234-€3,675▼ 198%
Operating profit (loss)9901-€1,234-€3,675▼ 198%
Financial income75/76B€1--
Recurring financial income75€1--
Financial charges65/66B€77€54▼ 29.4%
Recurring financial charges65€77€54▼ 29.4%
Profit (loss) for the period before taxes9903-€1,310-€3,729▼ 185%
Profit (loss) for the period9904-€1,310-€3,729▼ 185%
Profit (loss) for the period to be appropriated9905-€1,310-€3,729▼ 185%
Line20242025Change
Assets
Total assets20/58€2,489€1,147▼ 53.9%
Current assets29/58€2,489€1,147▼ 53.9%
Amounts receivable within one year40/41€440--
Trade receivables40€440--
Cash at bank and in hand54/58€2,049€1,147▼ 44.0%
Equity and liabilities
Total equity and liabilities10/49€2,489€1,147▼ 53.9%
Equity10/15€1,090-€2,639-
Contributions10/11€2,400€2,400=
Profit (loss) carried forward14-€1,310-€5,039▼ 285%
Amounts payable17/49€1,399€3,786▲ 171%
Amounts payable within one year42/48€1,399€3,786▲ 171%
Trade debts44€6€179▲ 31×
Suppliers440/4€6€179▲ 31×
Other amounts payable47/48€1,393€3,607▲ 159%
Line20242025Change
Profit (loss) for the period9904-€1,310-€3,729▼ 185%
Operating cash flow (approximation)-€1,310-€3,729▼ 185%
Change in cash--€902-

A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.

Download as CSV

Historical observation

In July 2024, 7,639 companies had the same profile as Ospoplus has now. Two years later, 84.9% were still going and 8.8% had gone bankrupt.

  • Micro
  • 2 to 5 years old
  • negative equity
  • a loss of 10% of the balance sheet or more
84.9% was still going
5.6% stopped otherwise
8.8% went bankrupt

Another 0.7% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of Ospoplus itself is lower: 0.2% within 12 months. It rests on far more data about Ospoplus than the profile alone.

Test of the method

The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,639 companies, not a prediction for Ospoplus. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Filings with the National Bank (2)
Financial year Type Filed Reference Document
31-12-2025 micro format 28-08-2026 2026-00491425 PDF
31-12-2024 micro format 30-06-2025 2025-00240598 PDF

Board & ownership

Directors

Directors
1 director, no change since 2026
DE WILDER Kenneth
Director (not named in the articles) · since 02-01-2026 · term without a fixed end · listed in the 2025 annual accounts, filed on 28-08-2026
Current
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“de meerderheid vormt in het bestuursorgaan, wordt de hoedanigheid van de voorzitter van het bestuursorgaan opgenomen in het register. De…”
deed of 20-06-2023

Owners and capital

Shareholders

At incorporation act of 20-06-2023 ↗
  • OSTEO VOET (BE 0790.414.792) 120 shares (50%) · €1,200
  • SOPHIE DONADI (BE 0795.427.813) 120 shares (50%) · €1,200

Capital transactions

Capital over time
  1. 20-06-2023 Incorporation · €2,400 · 240 shares

Mandate history

3 people, 1 in office
Show
  • Board
  • end not dated
Mandates per person, with start and end dates
Name Functions and periods
DE WILDER Kenneth
  • Director (not named in the articles), from 02-01-2026 to date
Osteo Voet
  • Director, appointed in the act of 20-06-2023, no longer listed in the 2025 annual accounts
Sophie Donadi
  • Director, appointed in the act of 20-06-2023, no longer listed in the 2025 annual accounts
See the board, name and registered office on a given date →

Network & group

Companies at the same address

1 other company

Connections & network

1 current director
Depth

The board mandates are listed under Board mandates elsewhere. The network lets you explore the same ties.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.

Timeline

Acts, filings and financial milestones

Deadline for the 2026 accounts: 31-07-2027
2026
28-08
NBB filing Annual accounts 2025 filedNBB
micro format · 28 days late
01-04
Gazette deed Appointment: DE WILDER Kenneth (director)
5 points ▸
  • General meeting, 02-01-2026
  • Director appointment, DE WILDER Kenneth (director (not named in the articles))
  • Director in office, Enya VOЕТ (director)
  • Director in office, Sophie DONADI (director)
  • Director in office, DE WILDER Kenneth (director)

Open the act in the Belgian Official Gazette

2025
30-06
NBB filing Annual accounts 2024 filedPDF
micro format · 31 days before the deadline
2023
20-06
Gazette deed Incorporation
Starting capital €2,400 · Appointments: OSTEO VOET (director) and SOPHIE DONADI (director) · Permanent representatives: VOET Enya and DONADI Sophie · Founder13 points ▸
  • Founder, OSTEO VOET
  • Founder, SOPHIE DONADI
  • Incorporation, “Ospoplus” (deed in Dutch)
  • Founding capital, €2,400
  • Other provision, 23-05-2023
  • Bank account, 2400, “dossier notaris” (deed in Dutch)
  • Declaration, “bevestiging deponering”, 2400 (deed in Dutch)
  • Director appointment, OSTEO VOET (director)
  • Permanent representative, VOET Enya
  • Director appointment, SOPHIE DONADI (director)
  • Permanent representative, DONADI Sophie
  • Permanent representative, DONADI Sophie (vaste vertegenwoordiger van de vennootschap)
  • The act holds 1 more point.

Open the act in the Belgian Official Gazette

Gazette deedNBB filing

Sources:Publications in the Belgian Official GazetteFilings with the National Bank

History

Ospoplus was incorporated on 16 June 2023 as a private limited company by OSTEO VOET and SOPHIE DONADI, with a starting capital of €2,400.12 Since 2026, DE WILDER Kenneth has served as director.3 The company has filed 2 sets of annual accounts, the latest for financial year 2025.3

  1. 1KBO register
  2. 2Belgian Official Gazette, 20-06-2023
  3. 3National Bank, annual accounts 2025

Company details

Register details

Identity

KBO record
Name Ospoplus in Dutch
Enterprise number 0802.820.104
Legal form Private limited company
Status Active, normale toestand
Founded 16-06-2023
Entity type Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 20-06-2023 (in Dutch)

Registered office and establishments

Registered office Groenstraat 41, 3078 Kortenberg, Belgium
Establishment unit Ospoplus, Groenstraat 41, 3078 Kortenberg since 16-06-2023 · unit number 2.346.258.566

Activities

NACEBEL 2025
86951 Physiotherapy main activity
47741 Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
85599 Other education
86995 Nutrition and dietetics services
Codes under NACEBEL 2008
86905 Human health activities main activity
47740 Retail trade
85599 Other education
86909 Human health activities

Invoicing and payment

VAT number BE 0802.820.104
E-invoicing via Peppol
Reachable via Peppol
Peppol ID 0208:0802820104
Registered 02-10-2025

Follow this company and you will hear the next morning if it leaves the Peppol register.

Register as of 2 November 2026 · Peppol Directory

Financial year and general meeting

Accounts at the NBB
Financial year end 31-12
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
First Saturday of June at 14:00
deed of 20-06-2023 (in Dutch)

Sites & property

Location
registered office establishment The establishment unit on the map
2 companies at this address See who is registered here

Buildings and parcels at the address

Ground area
606 m²
Building footprint
70 m²
Building volume
512 m³
Cadastral parcel Region Area Buildings Height / floors
24026D0127/00Y000 Flanders 606 m² 1 · 70 m² 8.8 m · 3